The (pro)renin receptor [(P)RR] is a 35-kDa transmembrane protein that plays a pivotal role
in angiotensin tissue generation and in nonproteolytic prorenin activation. We detected a …

The discovery of a (pro) renin receptor ((P) RR) and the introduction of renin inhibitors in the
clinic has brought prorenin, the inactive proenzyme form of renin, back into the spotlight. …

The National Cancer Institute Common Terminology Criteria for Adverse Events classification
is the standard classification used by the physicians in oncology for reporting adverse …

Glucose transporter type 1 (GLUT1) deficiency syndrome (GLUT1‐DS) leads to a wide
range of neurological symptoms. Ketogenic diets are very efficient to control epilepsy and …

Statin treatment of hypercholesterolemia can lead to chronic myotoxicity which is, in most
cases, alleviated by drug withdrawal. Cellular and molecular mechanisms of this adverse effect …

The renin-angiotensin system (RAS) is one of the most important systems in physiology and
in pathology. The (pro) renin receptor [(P) RR] is a new component of the system that has …

Introduction Les toxicités induites par les chimiothérapies peuvent générer des modifications
de prescription et de dose intensité relative, ayant un impact sur l’efficacité thérapeutique. …

Method This is a prospective observational study performed in hepato-gastroenterology
department for 6 months. All patients treated for colorectal cancer and beginning a protocol with …

Une validation initiale d’un guide de consultation pharmaceutique standardisé a été
réalisée dans un précédent travail pour optimiser l’adhésion médicamenteuse du patient au …

Background: Glucose transporter 1 (GLUT1) is a ubiquitously expressed protein highly
expressed on the surface of erythrocytes. As a member of insulin signaling pathway, GLUT1 is …